Perone Thomas Michael 4
4 · Ovid Therapeutics Inc. · Filed Jan 2, 2020
Insider Transaction Report
Form 4
Perone Thomas Michael
SVP, General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-01-01+75,000→ 75,000 totalExercise: $4.15Exp: 2030-12-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on January 1, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.